Sunshine Heart Inc. announced the U.S. Food and Drug Administration (FDA) has approved an amendment to the stopping rule criteria for the company's COUNTER HF pivotal study for its C-Pulse Heart Assist System. The agency has agreed to change this protocol from "all cause" deaths to specifically, mortality associated with device, procedure or therapy.

In a new study reported in The Journal of Thoracic and Cardiovascular Surgery, researchers found a dramatic difference in cardiac function recovery with extracorporeal life support (ECLS) after cardiogenic shock depending on the nature of the attack. The results underscore the importance of mechanical circulatory support in helping the patient survive.

Extending clot-preventing dual antiplatelet therapy (DAPT) beyond the recommended 12 months after coronary stenting “should be considered” in patients at low risk for bleeding, investigators for the OPTIDUAL trial recommend.


Today, in a world of immediate access to information anywhere on the planet using a smartphone, consumers expect more from healthcare, which many experts say will cause a major consumer-driven transformation in care delivery models. Technology has evolved to enable what many are calling the “Uberization” of healthcare, where patients will have instant access to healthcare, similar to the Uber app allowing instant access and online tracking for taxi services.


TRU-Vu Monitors has launched a new line of 24-inch HD surgical LCD monitors and touch screens.

Despite numerous major changes looming in the healthcare industry, the 2015 edition of the Great American Physician Survey found that U.S. physicians are still happy in their careers.

Subscribe Now